Physician

Najeff Waseem

According to 2025 Medicare claims, Najeff Waseem (NPI: 1598119711) practices internal medicine in the Baltimore-Columbia-Towson, MD market, with the plurality of this provider's patient population coming from Howard, MD. This provider's primary affiliated billing organization is MARYLAND ONCOLOGY HEMATOLOGY P.A. (NPI: 1396710703; TIN: 113652573) and primary practice location at 21044-3257.

Waseem's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 842 traditional Medicare patients, billed 237,157 HCPCS/CPT codes, and received $3,882,646 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 831 prescription claims across 157 beneficiaries totaling $2,707,595 in drug costs, led by Pomalyst (Pomalidomide). DME data shows 31 claims. Open Payments data shows 130 records totaling $75,418. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,570 to $2,707,595. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.9M$3.9M2022 Medicare payment: $347,903 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,006,547 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,882,646 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
202218127,262$347,903
2023562146,097$2,006,547
2024842237,157$3,882,646

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.4M$2.7M2018 Drug cost: $1,570 (USD; Tot_Drug_Cst)2019 Drug cost: $15,105 (USD; Tot_Drug_Cst)2020 Drug cost: $26,232 (USD; Tot_Drug_Cst)2021 Drug cost: $40,382 (USD; Tot_Drug_Cst)2022 Drug cost: $39,151 (USD; Tot_Drug_Cst)2023 Drug cost: $302,136 (USD; Tot_Drug_Cst)2024 Drug cost: $2,707,595 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R14$1,570
20192578$15,105
202024118$26,232
202126114$40,382
202253147$39,151
202395396$302,136
2024157831$2,707,595

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$7.9K$16K2023 Medicare payment: $15,829 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,046 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R42$15,829
2024N/R31$1,046

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more419988$102
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more225263$72
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's251396$14
96372Injection of drug or substance under skin or into muscle153407$12
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count4291,601$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
PomalystPomalidomide23644$571,790
RevlimidLenalidomide25700$378,429
RetevmoSelpercatinib11330$238,632
BrukinsaZanubrutinib15450$225,677
EliquisApixaban845,063$94,857

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8521Capecitabine, oral, 500 mgNN/R18$801
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R13$245

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.129$39,081Merck Sharp & Dohme LLC
Research PaymentsReported research-related payment or transfer-of-value amount.1$36,337AstraZeneca Pharmaceuticals LP
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Najeff Waseem?

Tedicare shows public-source Medicare data for Najeff Waseem (NPI 1598119711), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Najeff Waseem have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Najeff Waseem?

Najeff Waseem is linked to MARYLAND ONCOLOGY HEMATOLOGY P.A. (billing NPI 1396710703) in the available physician profile data.

Does Najeff Waseem have Open Payments data?

Najeff Waseem has 130 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.